Skeletal defects in Osterix-Cre transgenic mice

Wei Huang1, Bjorn R Olsen

  • 1Department of Developmental Biology, Harvard School of Dental Medicine, 188 Longwood Avenue, Boston, MA, 02115, USA, wei_huang@hms.harvard.edu.

Transgenic Research
|August 21, 2014
PubMed

Insights

Osterix-Cre (Osx-Cre) transgenic mice exhibit skeletal defects, including delayed bone formation and fracture healing. Researchers recommend using Osx-Cre controls for accurate skeletal studies involving this widely used gene-targeting tool.

Area of Science:

  • Molecular Biology
  • Genetics
  • Developmental Biology

Background:

  • Cre/loxP recombination is a key technology for conditional gene targeting in vivo.
  • This system enables significant discoveries in gene function for normal and disease biology.
  • Transgenic Cre mouse strains can exhibit unintended phenotypes, complicating research.

Purpose of the Study:

  • To investigate skeletal abnormalities in Osterix-Cre (Osx-Cre) transgenic mice.
  • To determine the necessity of Osx-Cre controls in skeletal research.
  • To highlight potential confounding factors in studies using Osx-Cre mice.

Main Methods:

  • Analysis of skeletal development in Osx-Cre transgenic mice.
  • Phenotypic characterization of bone ossification and fracture healing.
  • Comparative assessment of Osx-Cre mice and appropriate controls.

Main Results:

  • Osx-Cre mice displayed delayed calvarial ossification.
  • Multiple skeletal sites in Osx-Cre mice showed impaired fracture callus formation.
  • These findings indicate inherent skeletal defects in the Osx-Cre mouse model.

Conclusions:

  • Osterix-Cre (Osx-Cre) transgenic mice possess inherent skeletal defects.
  • Osx-Cre mice are unsuitable as controls for skeletal research without careful consideration.
  • Researchers must use appropriate Osx-Cre controls for in vivo and in vitro skeletal analyses.